This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benza, R. L. Articles by Booyse, F. M. Search for Related Content PubMed PubMed Citation Articles by Benza, R. L. Articles by Booyse, F. M. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Transplantation

(Circulation. 1998;98:2248-2254.)
© 1998 American Heart Association, Inc.

Clinical Investigation and Reports

Gene Polymorphisms for Plasminogen Activator Inhibitor-1/Tissue Plasminogen Activator and Development of Allograft Coronary Artery Disease

Raymond L. Benza, MD; Hernan E. Grenett, PhD; Robert C. Bourge, MD; James K. Kirklin, MD; David C. Naftel, PhD; Pablo F. Castro, MD; David C. McGiffin, MD; James F. George, PhD; ; Francois M. Booyse, PhD

From the Department of Medicine (R.L.B., H.E.G., R.C.B., P.F.C., F.M.B.), Division of Cardiovascular Disease, and the Department of Surgery (J.K.K., D.C.N., D.C.M., J.F.G.), Division of Cardiothoracic Surgery, University of Alabama at Birmingham.

Correspondence to Raymond L. Benza, MD, Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, 809 BBRB, 845 19th St S, Birmingham, AL 35294-2170. E-mail rbenza{at}cardio.dom.uab.edu

Background—Impaired fibrinolytic activity has been linked to the presence and severity of allograft vasculopathy (Tx CAD). This impairment may be associated with the presence of certain fibrinolytic protein gene polymorphisms.

Methods and Results—To investigate the relation between donor-specific fibrinolytic protein genotypes and Tx CAD, we identified donor plasminogen activator inhibitor-1 (PAI-1) HindIII and tissue plasminogen activator (TPA) EcoRI restriction fragment length polymorphisms–based genotypes by Southern blot analysis in 48 recipients of cardiac allografts and correlated these genotypes with the development of CAD. No association was found between donor TPA genotypes and the presence of Tx CAD. Among the 48 patients, 17% were homozygous for the 1/1 PAI-1 genotype, 51% for the 2/2 PAI-1 genotype, and 32% for the 1/2 PAI-1 genotype. The actuarial freedom from any CAD for the recipients with each respective donor PAI-1 genotype at 12 and 24 months was 100% and 100% for the 1/1 PAI-1 genotype, 92% and 92% for the 1/2 PAI-1 genotype, and 75% and 45% for the 2/2 PAI-1 genotype (P=0.03). Recipients with a diseased 2/2 PAI-1 genotyped allograft had longer ischemic times (P=0.02) than those recipients with a Tx CAD–free allograft.

Conclusions—These data suggest that recipients with a 2/2 PAI-1 genotype are at a significant risk of developing Tx CAD. This genotype may serve as a useful screening tool for predicting the future development of Tx CAD.

Key Words: coronary disease • fibrinolysis • genes • transplantation

This article has been cited by other articles:

				N. Torres-Carrillo, N. Magdalena Torres-Carrillo, M. Vazquez-Del Mercado, H. Rangel-Villalobos, I. Parra-Rojas, S. Sanchez-Enriquez, and J. Francisco Munoz-Valle Distribution of --844 G/A and Hind III C/G PAI-1 Polymorphisms and Plasma PAI-1 Levels in Mexican Subjects: Comparison of Frequencies Between Populations Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 220 - 226. [Abstract] [PDF]

				C. A. Labarrere, D. R. Nelson, C. J. Cox, D. Pitts, P. Kirlin, and H. Halbrook Cardiac-Specific Troponin I Levels and Risk of Coronary Artery Disease and Graft Failure Following Heart Transplantation JAMA, July 26, 2000; 284(4): 457 - 464. [Abstract] [Full Text] [PDF]

				J. L. Anderson, J. B. Muhlestein, J. Habashi, J. F. Carlquist, T. L. Bair, S. P. Elmer, and B. P. Davis Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1778 - 1783. [Abstract] [Full Text] [PDF]